H-1B & Green Card Salary Data and Market Analysis
Total Filings
All time (charts below use selected years)Median Salary
Across filings in selected periodTop Employers
Hiring This RoleSee all H-1B/PERM filings for this role →
| Employer | Filings | Median Salary | Salary Range | Approval Rate |
|---|---|---|---|---|
| HIKMA PHARMACEUTICALS USA INC. | 5 | $104,562 | $100,000 - $104,562 | 100.0% |
| Cerevel Therapeutics, LLC | 2 | $130,500 | $130,000 - $131,000 | 100.0% |
| Antares Therapeutics, Inc. | 1 | $190,000 | $190,000 - $190,000 | 100.0% |
| Pfizer Inc. | 1 | $118,331 | $118,331 - $118,331 | 100.0% |
| PTC Therapeutics, Inc. | 1 | $149,400 | $149,400 - $149,400 | 100.0% |
| ABBVIE BIORESEARCH CENTER | 1 | $155,000 | $155,000 - $155,000 | 100.0% |
| SAGE THERAPEUTICS | 1 | $180,000 | $180,000 - $180,000 | 0.0% |
| AbbVie Inc. | 1 | $160,000 | $160,000 - $160,000 | 100.0% |
| Experience Level | Filings | Median Salary | Salary Range |
|---|---|---|---|
| Principal | 13 | $130,000 | $100,000 - $190,000 |
| City | State | Filings | Median Salary |
|---|---|---|---|
| Columbus | OH | 5 | $104,562 |
| Cambridge | MA | 2 | $143,000 |
| Somerset | NJ | 2 | $145,000 |
| Andover | MA | 1 | $118,331 |
| Boston | MA | 1 | $190,000 |
| Bridgewater | NJ | 1 | $149,400 |
These roles are variations of Principal Scientist, Formulation Development with different seniority levels.
| Role | Experience Level | Filings | Avg Salary |
|---|---|---|---|
| Principal Scientist, Formulation Development | 16 | $126,276 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| 2023 | 2 | $117,781 | 100.0% |
| 2024 | 6 | $104,562 | 100.0% |
| 2025 | 4 | $157,500 | 75.0% |
| 2026 | 1 | $190,000 | 100.0% |
Compare how top companies pay for this role.
| Company | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| HIKMA PHARMACEUTICALS USA INC. | 5 | $104,562 | 100.0% |
| Cerevel Therapeutics, LLC | 2 | $130,500 | 100.0% |
| Antares Therapeutics, Inc. | 1 | $190,000 | 100.0% |
| Pfizer Inc. | 1 | $118,331 | 100.0% |
| PTC Therapeutics, Inc. | 1 | $149,400 | 100.0% |